ClinicalTrials.gg
RecruitingNCT05196906Updated Apr 11, 2025

The Clinical Outcomes of the Modified Broström vs Anatomic Reconstruction Operation in CLAI and GJL

An observational study in Ankle Sprains, Instability, Joint and Joint Hypermobility, sponsored by Peking University Third Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-04-11.

Sponsored by Peking University Third Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Investigators designed this prospective cohort study to compare the clinical outcomes of modified Broström operation and anatomical reconstruction for the treatment of CLAI and GJL.

Read the detailed description

The modified Broström operation is still the first line to treat chronic lateral ligament instability (CLAI). However, some studies indicate the modified Broström operation may bring a higher rate of re-injury in generalized joint laxity (GJL). Anatomical reconstruction was reported to generate similar results and less rate of re-injury compared in patients with CLAI. However, the clinical outcomes of the two operations are not discussed in CLAI and GJL. So, investigators designed this prospective cohort study. The primary outcomes are Karlsson, Foot and Ankle Outcome Score (FAOS), and Foot and Ankle Ability Measure (FAAM) scores. The secondary outcomes are anterior displacement and talar tilt angle in stress radiography, the rate of re-injury.

02

Conditions studied

  • Ankle Sprains
  • Instability, Joint
  • Joint Hypermobility

Keywords

  • chronic lateral ankle instability
  • generalized joint laxity
  • re-injury
  • modified Brostrom operation
  • anatomic reconstruction
03

In context

Ankle Injuries

350 studies on the registry are indexed under Ankle Injuries; 74 are open to participants now.

This study's planned enrollment of 100 is above the median of 84 across 73 observational studies indexed under Ankle Injuries.

Browse Ankle Injuries studies →

Lead sponsor

Peking University Third Hospital is the lead sponsor of 752 studies on the registry; 273 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The patients who go to visit a doctor for persistent lateral ankle pain and instability over three months and invalid conservative treatment, with the age of 16- 50 years. If the Beighton score of the patient is ≥4 and the exclusion criteria are met, he or she is going to be advised to participate in this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Clinical diagnosis of lateral ankle pain and instability Beighton score ≥4 Age with 18 to 60 years

Exclusion criteria

Exclusion Criteria:

Patients with an acute or subacute ankle injury (within 3 months) Injury of the deltoid ligament Alignment of lower extremity greater than 5 degrees Fractures of the lower extremity Stage III or IV osteoarthritis Patients who refused to participate in the study

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Modified Broström operation group

    Patients who accept a modified Broström operation

    Procedure: Modified Broström operation and anatomic reconstruction operation

  • Anatomic reconstruction operation group

    Patients who accept an anatomic reconstruction

    Procedure: Modified Broström operation and anatomic reconstruction operation

Interventions

  • ProcedureModified Broström operation and anatomic reconstruction operation

    Patients with CLAI and GJL will accept the Modified Broström operation or anatomic reconstruction operation.

06

What researchers measure

Primary outcomes

  1. Karlsson score

    This score is a primary scale for lateral ankle instability

    Time frame: postoperative Karlsson score at 1 year.

  2. Karlsson score

    This score is a primary scale for lateral ankle instability

    Time frame: postoperative Karlsson score at 2 years.

Secondary outcomes

  1. Anterior displacement and talar tilt angle in stress radiography

    The outcomes are common indicators for evaluation the lateral stability of ankle

    Time frame: postoperative radiographic measures at 2 years.

Other outcomes

  1. Rate of re-injury

    After surgery, the rate of patients re-sprain

    Time frame: the rate of re-injury at 2 years.

  2. Signal to noise value of the anterior talofibular ligament

    Signal to noise value of the anterior talofibular ligament

    Time frame: 6 months post-treatment

  3. Signal to noise value of the anterior talofibular ligament

    Signal to noise value of the anterior talofibular ligament

    Time frame: 12 months post-treatment

  4. Signal to noise value of the anterior talofibular ligament

    Signal to noise value of the anterior talofibular ligament

    Time frame: 2 years post-treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • de Vries JS, Krips R, Sierevelt IN, Blankevoort L, van Dijk CN. Interventions for treating chronic ankle instability. Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004124. doi: 10.1002/14651858.CD004124.pub3. PubMed 21833947 ↗
  • Michels F, Cordier G, Guillo S, Stockmans F; ESKKA-AFAS Ankle Instability Group. Endoscopic Ankle Lateral Ligament Graft Anatomic Reconstruction. Foot Ankle Clin. 2016 Sep;21(3):665-80. doi: 10.1016/j.fcl.2016.04.010. PubMed 27524711 ↗
  • Sacks HA, Prabhakar P, Wessel LE, Hettler J, Strickland SM, Potter HG, Fufa DT. Generalized Joint Laxity in Orthopaedic Patients: Clinical Manifestations, Radiographic Correlates, and Management. J Bone Joint Surg Am. 2019 Mar 20;101(6):558-566. doi: 10.2106/JBJS.18.00458. No abstract available. PubMed 30893238 ↗
  • Xu HX, Lee KB. Modified Brostrom Procedure for Chronic Lateral Ankle Instability in Patients With Generalized Joint Laxity. Am J Sports Med. 2016 Dec;44(12):3152-3157. doi: 10.1177/0363546516657816. Epub 2016 Aug 5. PubMed 27496909 ↗
  • Park KH, Lee JW, Suh JW, Shin MH, Choi WJ. Generalized Ligamentous Laxity Is an Independent Predictor of Poor Outcomes After the Modified Brostrom Procedure for Chronic Lateral Ankle Instability. Am J Sports Med. 2016 Nov;44(11):2975-2983. doi: 10.1177/0363546516656183. Epub 2016 Aug 1. PubMed 27480980 ↗

Individual participant data

Plan to share: No — The demographics data, Beighton score, primary and secondary outcomes would be available to other researchers

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2020 (actual). Primary completion is estimated for Dec 2025, 71 months after the start.

Of 34 non-industry observational studies under Ankle Injuries, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's planned 71 months is above that.

Counting every sponsor, half of 38 studies reached it within 11 months; a quarter within 5 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 27, 2021
First posted
Jan 19, 2022
StartActual
Jan 1, 2020
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Apr 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05196906
Responsible party
Jiang Dong (Chief physician, Peking University Third Hospital) — Principal investigator
First posted
Jan 19, 2022
Start date
Jan 1, 2020
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Apr 11, 2025

Study contacts

Dong Jiang, MD
Contact
bysyjiangdong@126.com
13811280948
Anhong Wang, MD
Contact
1811210533@pku.edu.cn
18501325799
Dong Jiang, MD
principal investigator · Peking University Third Hosptial

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion